|
back to main APP Mutations Directory
Updated 2 April 2010
View APP Mutations Diagram
by John Hardy, National Institute on Aging, Bethesda, MD, and Richard Crook, MD.,
Mayo Clinic, Jacksonville, FL.
Disease-associated intra-Aβ mutations
(courtesy of Dominic Walsh)
|
Mutation
|
Phenotype
|
Age of Onset
|
References
|
|
E665D
|
AD, but may not be pathogenic
|
86?
|
Peacock, et al., 1994
|
|
KM670/671NL (Swedish)
|
AD
|
52 (44-59)
|
Mullan, et al. 1992
|
|
A673T
|
Normal
|
N/A
|
Peacock, et al. 1993
|
|
H677R
|
AD
|
55 (55-56)
|
Janssen, et al. 2003
|
|
D678N (Tottori)
|
FAD
|
60
|
Wakutani, et al. 2004
|
|
A692G (Flemish)
|
Large dense core plaques linked to CAA
|
40-60 but variable
|
Kumar-Singh et al,
2002
Hendriks, et al. 1992
Cras, et al. 1998
Roks, et al. 2000
|
|
E693Δ
|
AD
|
|
Tomiyama et al., 2008
|
|
E693G (Arctic)
|
AD
Severe congophilic angiopathy, abundant amyloid plaques with a characteristic ringlike
character, no brain haemorrhage
|
Age at disease onset ranged from 52 years to 65 years with a mean age of 56.9 (+/-1.1)
years
N/A
|
Kamino et al., 1992
Nilsbeth et al., 2001
Basun et al., 2008
|
|
E693K
|
Cerebral Hemorrhage
|
?
|
Tagliavini, et al. 1999 (no abstract avail.)
|
|
E693Q (Dutch)
|
HCHWA-D (a stroke syndrome)
|
Typically ~50 but variable
|
Van Broeckhoven, et
al. 1990
|
|
D694N (Iowa)
|
AD or Cerebral Hemorrhage
|
69
|
Grabowski, et al. 2001
|
|
A713T
|
AD, but may not be pathogenic
|
59
|
Carter, et al., 1992
|
|
A713V
|
Schizophrenia: probably not pathogenic
|
?
|
Jones, et al. 1992
|
|
T714A (Iranian)
|
AD
|
52 (40-60)
|
Pasaler, et al., 2002
|
|
T714I (Austrian)
|
Phenotype: Affects γ-secr cleavage directly, 11X increase in Aβ(42)/Aβ(40)
ratio in vitro. In brain, abundant and predominant nonfibrillar pre-amyloid plaques
composed primarily of N-truncated Aβ(42) in complete absence of Aβ(40).
|
|
Kumar-Singh, et al.
|
|
V715A (German)
|
AD
|
47
|
De Jonghe, et al., 2001;
Cruts, et al., 2003
|
|
V715M (French)
|
AD
|
52 (40-60)
|
Ancolio, et al., 1999
|
|
I716F
|
|
|
Guerreiro et
al., 2008
|
|
I716T
|
AD
|
55
|
Terrini, et al., 2002
|
|
I716V (Florida)
|
AD
|
55
|
Eckman, et al., 1997
|
|
V717F (Indiana)
|
AD
|
47 (42-52)
|
Murrell, et al. 1991
|
|
V717G
|
AD
|
55 (45-62)
|
Chartier-Harlin, et
al. 1991
|
|
V717I (London)
|
AD
|
55 (50-60)
|
Goate, et al. 1991
|
|
V717L
|
CSF tau and A-β consistent with AD; earlier onset than other 717 mutations
|
38
|
Murrell, et al., 2000
|
|
T719P
|
AD
|
46
|
Ghidoni et al., 2009
|
|
L723P (Australian)
|
AD
|
56 (45-60)
|
Kwok JB,
2000
|
|